自从肺磁共振成像（MRI）开始在临床上应用以来，一直存在对将MRI应用于肺部疾病的临床价值有限的观点。此外，由于临床指征、医疗保险类型或可用的MR设备数量的不同，MRI在治疗肺部疾病或胸部肿瘤的临床应用在不同国家可能存在差异。鉴于这种情况，Fleischner学会和日本磁共振医学学会的成员已经发表了新的报告，以提供肺部MRI的适当临床指征。本综述文章从技术角度和主要临床指征的角度简述了肺部MRI的历史，包括（1）目前可用的技术；（2）有前景但需要进一步验证或评估的技术；（3）需要基于研究的评估在临床前或患者研究中的技术发展。我们希望本文能够提供《Investigative Radiology》读者进一步了解肺部MRI的当前状况，并帮助他们在例行临床实践中应用适当的协议。 版权所有© 2023 Wolters Kluwer Health，Inc，保留所有权利。

Since lung magnetic resonance imaging (MRI) became clinically available, limited clinical utility has been suggested for applying MRI to lung diseases. Moreover, clinical applications of MRI for patients with lung diseases or thoracic oncology may vary from country to country due to clinical indications, type of health insurance, or number of MR units available. Because of this situation, members of the Fleischner Society and of the Japanese Society for Magnetic Resonance in Medicine have published new reports to provide appropriate clinical indications for lung MRI. This review article presents a brief history of lung MRI in terms of its technical aspects and major clinical indications, such as (1) what is currently available, (2) what is promising but requires further validation or evaluation, and (3) which developments warrant research-based evaluations in preclinical or patient studies. We hope this article will provide Investigative Radiology readers with further knowledge of the current status of lung MRI and will assist them with the application of appropriate protocols in routine clinical practice.Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.